In a move aimed at bolstering its position in the healthcare sector, Thyrocare Technologies has announced the acquisition of Chennai-based Think Health Diagnostics. This acquisition underscores Thyrocare’s commitment to enhancing its offerings and extending its reach in the pre-policy medical check-up segment, particularly for the insurance market.

With this development, Thyrocare ventures into the domain of home electrocardiogram (ECG) services, a significant addition to its repertoire. By integrating Think Health Diagnostics’ expertise in conducting ECGs at home, Thyrocare aims to provide a comprehensive solution to insurance partners, streamlining the process of pre-policy medical assessments.

Piyush Singh, Head of Partnerships at Thyrocare Technologies, expressed enthusiasm about the alignment between Think Health Diagnostics’ capabilities and Thyrocare’s strategic objectives. Singh stated, “Think Health Diagnostics’ great work in doing ECGs at home fits perfectly with our plans for the Pre-Policy Medical Check-Up market.”

The synergies resulting from this acquisition are poised to revolutionize healthcare accessibility across the country. Leveraging Think Health’s operational presence in key cities such as Ahmedabad, Bangalore, Chennai, Delhi, Hyderabad, Kanpur, Mumbai, Pune, Surat, and Jaipur, Thyrocare aims to extend its services to over 100 cities within the next year.

The merger brings together Thyrocare’s extensive network of over 900 blood collection phlebotomists with Think Health’s proficiency in home healthcare technology and ECG services. This collaborative effort creates a formidable network of over 100 trained phlebotomists equipped to administer ECGs at patients’ homes, ensuring enhanced service delivery and a seamless patient experience.

Karkavel, CEO & Director of Think Health Diagnostics, expressed optimism about the acquisition, highlighting its significance in the company’s growth trajectory. “Together, we will leverage our extensive network and expertise to create an unparalleled offering, delivering seamless healthcare directly to patients’ doorsteps,” remarked Karkavel.

Thyrocare Technologies, known for its automated laboratory chain spanning over 2000 cities nationally and internationally, remains committed to delivering quality diagnostic services. This acquisition marks yet another milestone in Thyrocare’s journey towards advancing healthcare accessibility and convenience for individuals across the country.

In 2021, Thyrocare Technologies garnered attention when Pharmeasy acquired a 66 per cent stake in the company for ₹4,546 crore, reflecting the industry’s recognition of Thyrocare’s significant presence and potential within the healthcare landscape.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!